Trials / Active Not Recruiting
Active Not RecruitingNCT03819712
Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Academic / Other
- Sex
- Female
- Age
- 18 Years – 28 Years
- Healthy volunteers
- Accepted
Summary
Urinary tract infections affect more than 130 million people worldwide each year. Almost 50% of women will have at least one urinary tract infection during their lifetime, usually cystitis. Half of them will have recurrent cystitis. Antibiotics are the first-line treatment for cystitis, but their effectiveness is decreasing due to the rapid spread of multi-resistant uro-pathogenic bacteria. The objective of this study is to identify blood biomarkers associated with a high risk of recurrent cystitis. Immune system cells, and more specifically innate immunity cells, play a key role in controlling urinary tract infections. In addition, clinical studies have shown that there is a high inter-individual variability in the ability of innate immune cells to respond to different stimuli. We therefore hypothesized that there was an association between the risk of recurrent cystitis and a deficiency of certain immune cell types in producing certain pro-inflammatory cytokines, including TNF-α, in response to one or more bacterial stimuli, particularly flagellin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Collection of blood samples | 23 mL of blood will be collected during the inclusion visit |
| OTHER | Collection of fecal samples | Fecal sample self-collected after the inclusion visit |
| OTHER | Collection of urine samples | 10 mL of urine will be collected during the inclusion visit |
| OTHER | Collection of vaginal swaps | Sample of vaginal microbiota collected during the inclusion visit |
Timeline
- Start date
- 2019-06-03
- Primary completion
- 2023-12-03
- Completion
- 2025-12-31
- First posted
- 2019-01-28
- Last updated
- 2025-12-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03819712. Inclusion in this directory is not an endorsement.